OsteoSelect DBM Putty is processed human bone that has been combined with an absorbable carrier, which makes it easier to handle during orthopedic surgical procedures. It received its first FDA 510(k) clearance in September 2009.
“The succession of proven osteoinductive results for every lot of OsteoSelect processed by Bacterin over the past five years demonstrates the superiority of our patented and patent-pending demineralization technologies,” said Gregory Juda, Bacterin’s chief scientific officer. “We look forward to implementing our demineralization processes in new product development as we continue to expand our product portfolio.”
More articles on devices:
Medtronic’s VERTEX Reconstruction System receives FDA approval for expanded indications
Sonoma Orthopedic Products receives FDA clearance for FibuLock Nail
Argus raises Integra Lifesciences’ price target to $61
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
